Cargando…
Evaluation of the immunogenicity of vaccine candidates developed using a baculovirus surface display system for Crimean-Congo hemorrhagic fever virus in mice
Crimean-Congo hemorrhagic fever (CCHF), which has a fatality rate of 20–30%, is widely prevalent in several regions in Asia, Europe, and Africa and has spread to a wider range of areas in recent years. At present, there is a lack of safe and effective vaccines for the prevention of CCHF. In this stu...
Autores principales: | Zhang, Gang, Wang, Pu, Jiang, Lingling, Wang, Sheng, Zhang, Sinong, Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061074/ https://www.ncbi.nlm.nih.gov/pubmed/37007525 http://dx.doi.org/10.3389/fmicb.2023.1107874 |
Ejemplares similares
-
Evaluation of the immunogenicity of a Crimean-Congo hemorrhagic fever virus vaccine candidate in mice developed based on a baculovirus Zera nanoparticle delivery system
por: Zhang, Gang, et al.
Publicado: (2023) -
An Update on Crimean Congo Hemorrhagic Fever
por: Appannanavar, Suma B, et al.
Publicado: (2011) -
Crimean-Congo Hemorrhagic Fever in Bulgaria
por: Papa, Anna, et al.
Publicado: (2004) -
Crimean-Congo Hemorrhagic Fever in Turkey
por: Karti, S. Sami, et al.
Publicado: (2004) -
Crimean-Congo Hemorrhagic Fever, Mauritania
por: Nabeth, Pierre, et al.
Publicado: (2004)